STAT5 regulates glioma cell invasion by pathways dependent and independent of STAT5 DNA binding

Neuroscience Letters

Volumn 487, Issue 2, 2011, Pages 228-233

  Cao, Shouqiang ^a   Wang, Chao ^a   Zheng, Qian ^a   Qiao, Ying ^b   Xu, Ke ^b   Jiang, Tao ^c   Wu, Anhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b First Affiliated Hospital of China Medical University   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Invasion; Phosphorylation; STAT5

Indexed keywords

EPIDERMAL GROWTH FACTOR; OLIGONUCLEOTIDE; SMALL INTERFERING RNA; STAT5 PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; ASTROCYTOMA; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GLIOBLASTOMA; GLIOMA; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

CELL LINE, TUMOR; DNA; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; PROTEIN BINDING; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 78650183431     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.10.028     Document Type: Article

References (24)

1. Amorino G.P., Deeble P.D., Parsons S.J. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway. Oncogene 2007, 26:745-756.
2. Bernaciak T.M., Zareno J., Parsons J.T., Silva C.M. A novel role for signal transducer and activator of transcription 5b (STAT5b) in beta1-integrin-mediated human breast cancer cell migration. Breast Cancer Res. 2009, 11:R52.
3. Buitenhuis M., Coffer P.J., Koenderman L. Signal transducer and activator of transcription 5 (STAT5). Int. J. Biochem. Cell Biol. 2004, 36:2120-2124.
4. F. Burel-Vandenbos, M. Benchetrit, C. Miquel, D. Fontaine, R. Auvergne, C. Lebrun-Frenay, N. Cardot-Leccia, J.F. Michiels, V. Paquis-Flucklinger, T. Virolle, EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis, J. Neurooncol. (2010), doi:10.1007/s11060-010-0308-4.
5. Calo V., Migliavacca M., Bazan V., Macaluso M., Buscemi M., Gebbia N., Russo A. STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 2003, 197:157-168.
6. Cutroneo K.R., Ehrlich H. Silencing or knocking out eukaryotic gene expression by oligodeoxynucleotide decoys. Crit. Rev. Eukaryot. Gene Expr. 2006, 16:23-30.
7. Ekstrand A.J., James C.D., Cavenee W.K., Seliger B., Pettersson R.F., Collins V.P. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 1991, 51:2164-2172.
8. Harris R.C., Chung E., Coffey R.J. EGF receptor ligands. Exp. Cell Res. 2003, 284:2-13.
9. Hatanpaa K.J., Burma S., Zhao D., Habib A.A. Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia 2010, 12:675-684.
10. Kirken R.A., Erwin R.A., Wang L., Wang Y., Rui H., Farrar W.L. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells. J. Immunol. 2000, 165:5097-5104.
11. Lewis R.S., Ward A.C. Stat5 as a diagnostic marker for leukemia. Expert Rev. Mol. Diagn. 2008, 8:73-82.
12. Lin J.X., Mietz J., Modi W.S., John S., Leonard W.J. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J. Biol. Chem. 1996, 271:10738-10744.
13. Mishima K., Higashiyama S., Asai A., Yamaoka K., Nagashima Y., Taniguchi N., Kitanaka C., Kirino T., Kuchino Y. Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas. Acta Neuropathol. 1998, 96:322-328.
14. Nakamura J.L. The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications. Expert Opin. Ther. Targets 2007, 11:463-472.
15. Nam S., Williams A., Vultur A., List A., Bhalla K., Smith D., Lee F.Y., Jove R., Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells. Mol. Cancer Ther. 2007, 6:1400-1405.
16. Paukku K., Valgeirsdottir S., Saharinen P., Bergman M., Heldin C.H., Silvennoinen O. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases. Biochem. J. 2000, 345(Pt 3):759-766.
17. Schmidt-Arras D, Schwable J., Bohmer F.D., Serve H. Flt3 receptor tyrosine kinase as a drug target in leukemia. Curr. Pharm. Des. 2004, 10:1867-1883.
18. Sonabend A.M., Dana K., Lesniak M.S. Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma. Expert Rev. Anticancer Ther. 2007, 7:S45-S50.
19. Sonnweber B., Dlaska M., Skvortsov S., Dirnhofer S., Schmid T., Hilbe W. High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC). J. Clin. Pathol. 2006, 59:255-259.
20. Tan S.H., Nevalainen M.T. Signal transducer and activator of transcription 5A/B in prostate and breast cancers. Endocr. Relat. Cancer 2008, 15:367-390.
21. van den Bent M.J., Brandes A.A., Rampling R., Kouwenhoven M.C., Kros J.M., Carpentier A.F., Clement P.M., Frenay M., Campone M., Baurain J.F., Armand J.P., Taphoorn M.J., Tosoni A., Kletzl H., Klughammer B., Lacombe D., Gorlia T. Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034. J. Clin. Oncol. 2009, 27:1268-1274.
22. Varela M., Ranuncolo S.M., Morand A., Lastiri J., De Kier Joffe E.B., Puricelli L.I., Pallotta M.G. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas. J. Surg. Oncol. 2004, 86:34-40.
23. Wu A., Ericson K., Chao W., Low W.C. NFAT and AP1 are essential for the expression of a glioblastoma multiforme related IL-13Ra2 transcript. Cell Oncol. 2010, 32:313-329.
24. Yang J., Stark G.R. Roles of unphosphorylated STATs in signaling. Cell Res. 2008, 18:443-451.